LATAM MedTech Insights
By Ran Chen
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Ran Chen
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 188
Description
Welcome to LATAM MedTech Insights, your essential guide to the booming medical technology and digital health sector across Latin America. Each episode, we dissect the key trends, investment opportunities, and regulatory news shaping the industry. Join us for in-depth interviews with the innovators, investors, and policymakers driving the future of healthcare from Mexico to Brazil.
| Episode | Date |
|---|---|
|
Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap
|
May 07, 2026 |
|
Pure Global: Chile's MedTech Surprise - Cracking Decree 25's Hidden Regulatory Hurdles.
|
May 06, 2026 |
|
Brazil's AI MedTech Firewall: Pure Global on Cracking ANVISA's Surprise Cybersecurity Mandate
|
May 05, 2026 |
|
Pure Global: Brazil's New SaMD Hurdle & The Hidden AI Challenge
|
May 04, 2026 |
|
Pure Global: Brazil's AI MedTech Shock—Navigating ANVISA's New Data Rules.
|
May 03, 2026 |
|
Pure Global: Brazil's AI MedTech Maze - Cracking ANVISA's New Software Rules
|
May 01, 2026 |
|
Pure Global: Brazil's AI Device Maze - Decoding ANVISA's Unseen SaMD Hurdles
|
Apr 30, 2026 |
|
Pure Global: Brazil's AI MedTech Surge - Unlocking ANVISA's New Fast-Track Secrets.
|
Apr 29, 2026 |
|
Brazil's ANVISA Gambit: Decoding the 2027 MedTech Agenda | Pure Global Insights
|
Apr 28, 2026 |
|
Brazil's Cyber Shock: Pure Global on ANVISA's Hidden Hurdles for Connected Devices.
|
Apr 27, 2026 |
|
Pure Global: Mexico's COFEPRIS Platform - Navigating the Hidden Digital Submission Traps.
|
Apr 26, 2026 |
|
Pure Global: Brazil's AI MedTech Fast-Track, Decoding ANVISA's Hidden Compliance Hurdles
|
Apr 25, 2026 |
|
Pure Global: Brazil's AI Software Gambit - Decoding ANVISA's New Compliance Maze.
|
Apr 24, 2026 |
|
Pure Global: Costa Rica's MedTech Gambit - The New Local-Only Fast Track
|
Apr 23, 2026 |
|
Pure Global: Brazil's ANVISA Shift – Cracking the Code of the New RDC 751 Landscape.
|
Apr 22, 2026 |
|
Brazil's AI MedTech Surprise: Pure Global on ANVISA's New Rulebook & Hidden Data Traps
|
Apr 21, 2026 |
|
Pure Global: Brazil's MedTech Renewal Riddle - Cracking ANVISA's New 10-Year Cycle.
|
Apr 20, 2026 |
|
Pure Global: Brazil's ANVISA Deadline Chaos - A Survival Guide for MedTech.
|
Apr 19, 2026 |
|
Mexico's Digital Gate: Pure Global on COFEPRIS's Chaotic New Platform.
|
Apr 18, 2026 |
|
Pure Global's Brazil Brief: Decoding ANVISA's New AI Rules for MedTech Innovators.
|
Apr 17, 2026 |
|
Pure Global: Brazil's New ANVISA Gambit - Cracking the Code on Fast-Track Registration
|
Apr 16, 2026 |
|
Pure Global: Brazil's AI MedTech Rules – Decoding ANVISA's New Compliance Traps
|
Apr 15, 2026 |
|
Brazil's AI MedTech Shortcut: Cracking ANVISA's New Rules with Pure Global
|
Apr 14, 2026 |
|
Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Data Walls.
|
Apr 13, 2026 |
|
Pure Global: Brazil's Sudden MedTech Shift - Decoding ANVISA's New Equivalence Mandate.
|
Apr 12, 2026 |
|
Pure Global: Brazil's AI Diagnostic Boom & The New Cybersecurity Gauntlet.
|
Apr 11, 2026 |
|
Brazil's AI MedTech Gambit: Pure Global Decodes ANVISA's High-Stakes Regulatory Shift.
|
Apr 10, 2026 |
|
Brazil's New Data Maze: Pure Global on Unseen Traps in ANVISA's SaMD Cybersecurity Rules.
|
Apr 09, 2026 |
|
Brazil's New MedTech Shortcut: Pure Global on ANVISA's Reliance Gambit
|
Apr 08, 2026 |
|
Pure Global: Brazil's New SaMD Rules, Unlocking the AI MedTech Backdoor
|
Apr 07, 2026 |
|
Pure Global: Brazil's New AI Rules - A Stifling Dilemma for Local MedTech Innovators?
|
Apr 06, 2026 |
|
Brazil's SaMD Shock: Pure Global's Guide to ANVISA's New Rules
|
Apr 05, 2026 |
|
Pure Global: Brazil's UDI Deadline Chaos - A MedTech Compliance Crisis.
|
Apr 04, 2026 |
|
Pure Global: Brazil's SaMD Shift & The Unseen Data Trap
|
Apr 03, 2026 |
|
Pure Global: Brazil's AI Diagnostic Maze, Cracking ANVISA's New Rules
|
Apr 02, 2026 |
|
Pure Global: Brazil's Sudden SaMD Shockwave - The Unforeseen ANVISA Cybersecurity Mandate
|
Apr 01, 2026 |
|
Brazil's AI Gold Rush: Navigating the LGPD Data Maze with Pure Global
|
Mar 31, 2026 |
|
Pure Global: Brazil's AI Rulebook - Cracking the New Medical AI Framework
|
Mar 30, 2026 |
|
Brazil's AI Fast-Track: Pure Global on Cracking ANVISA's 90-Day Approval Code.
|
Mar 29, 2026 |
|
Pure Global: Brazil's New MedTech Shortcut & ANVISA's Hidden Compliance Toll.
|
Mar 28, 2026 |
|
Brazil's AI MedTech Crackdown: Pure Global on ANVISA's New Cybersecurity Demands
|
Mar 27, 2026 |
|
Pure Global: Mexico's FDA Fast-Track - The COFEPRIS Secret Handshake for 510(k) Devices
|
Mar 26, 2026 |
|
Pure Global: Brazil's MedTech Compliance & ANVISA's New Hidden Hurdles.
|
Mar 25, 2026 |
|
Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Privacy Traps.
|
Mar 24, 2026 |
|
Pure Global: Brazil's SaMD Cyber Wall - Hacking ANVISA's Hidden MedTech Rule
|
Mar 23, 2026 |
|
Pure Global: Brazil's AI Device Gambit - ANVISA's Fast-Track Hides a Costly Data Trap.
|
Mar 22, 2026 |
|
Pure Global: Brazil's SaMD Cyber Shock—Cracking ANVISA's Hidden Compliance Traps
|
Mar 21, 2026 |
|
Pure Global: Brazil's ANVISA RDC 751 - Navigating the Hidden Post-Implementation Hurdles.
|
Mar 20, 2026 |
|
Pure Global: Brazil's ANVISA Shakeup - Navigating MedTech's Hidden Compliance Traps.
|
Mar 19, 2026 |
|
Brazil's AI MedTech Shock: Pure Global on ANVISA's Sudden New Data Demands.
|
Mar 18, 2026 |
|
Pure Global: Cracking Brazil's New IVD Code Under ANVISA's RDC 830
|
Mar 17, 2026 |
|
Pure Global: Brazil's AI Gambit - Decoding CFM's Unwritten MedTech Rules.
|
Mar 16, 2026 |
|
Pure Global: Brazil's Cyber Shock - Navigating ANVISA's New MedTech Rules
|
Mar 15, 2026 |
|
Pure Global: Brazil's AI MedTech Fast-Track or a Hidden Data Privacy Trap?
|
Mar 14, 2026 |
|
Pure Global: Brazil's ANVISA Sets a SaMD Trap. Are You Compliant?
|
Mar 13, 2026 |
|
Pure Global: Brazil's SaMD Shift, Cracking ANVISA's Unseen AI Regulatory Code
|
Mar 12, 2026 |
|
Brazil's New UDI Maze: Pure Global on Dodging Hidden Data Traps in ANVISA's System.
|
Mar 11, 2026 |
|
Pure Global: Brazil's IVD Shake-Up & ANVISA's Secret Fast-Track Angle
|
Mar 10, 2026 |
|
Pure Global: Brazil's UDI Shockwave - Navigating ANVISA's New MedTech Compliance Maze.
|
Mar 09, 2026 |
|
Brazil's New MedTech Rules: Pure Global on Cracking the RDC 751 Code
|
Mar 08, 2026 |
|
Pure Global: Brazil's AI MedTech Gold Rush - Unlocking ANVISA's New Fast-Track
|
Mar 07, 2026 |
|
Pure Global: Brazil's UDI Shockwave, ANVISA's Hidden Compliance Trapdoor for MedTech.
|
Mar 06, 2026 |
|
Pure Global | Brazil's ANVISA Shock: Navigating the New UDI Traceability Maze for MedTech
|
Mar 05, 2026 |
|
Pure Global: Brazil's AI MedTech Approval - Hacking ANVISA's New Digital Maze.
|
Mar 04, 2026 |
|
Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's Risky Fast-Track
|
Mar 03, 2026 |
|
Brazil's ANVISA Digital Chaos: Pure Global on High-Risk Device Submission Secrets
|
Mar 01, 2026 |
|
Pure Global: Brazil's AI MedTech Brief—Decoding ANVISA's Sudden SaMD Rule Shift.
|
Feb 28, 2026 |
|
Pure Global: Brazil & Mexico's MedTech Manufacturing - The Local Production Gambit.
|
Feb 27, 2026 |
|
Pure Global: Cracking Brazil's New MedTech Cybersecurity Code - ANVISA's Unexpected Hurdle.
|
Feb 26, 2026 |
|
Pure Global: Brazil's MedTech Fast-Track - The Hidden Cost of ANVISA's New Rules
|
Feb 25, 2026 |
|
Pure Global: Brazil's New Device Regs & The Risk Management Blind Spot.
|
Feb 24, 2026 |
|
Pure Global: Brazil's AI MedTech Gambit—Navigating ANVISA's New Fast-Track Paradox.
|
Feb 23, 2026 |
|
Pure Global: Brazil's SaMD Shake-Up - Navigating ANVISA's Unseen AI Hurdles
|
Feb 22, 2026 |
|
Pure Global: Brazil's High-Risk Device Code Unlocked - The New ANVISA Reliance Shortcut.
|
Feb 21, 2026 |
|
Brazil's AI Diagnostic Gold Rush: Pure Global on ANVISA's Hidden Data Hurdles
|
Feb 20, 2026 |
|
Brazil's SaMD Cybersecurity: Pure Global on ANVISA's Hidden Data Demands.
|
Feb 19, 2026 |
|
Brazil SaMD Shake-Up: Pure Global on ANVISA's Hidden Compliance Traps
|
Feb 18, 2026 |
|
Pure Global: Brazil's AI MedTech Gold Rush. ANVISA's Secret Fast-Track to Market Access.
|
Feb 17, 2026 |
|
Brazil's RDC 751 Maze: Pure Global on MedTech Registration's Hidden Traps
|
Feb 15, 2026 |
|
Pure Global: Brazil's New SaMD Hurdle & ANVISA's Unspoken Rules.
|
Feb 14, 2026 |
|
Pure Global: Brazil's SaMD Surprise—Decoding ANVISA's Hidden Cybersecurity Rules
|
Feb 13, 2026 |
|
Brazil's SaMD Surprise: Hacking ANVISA's New Rules | A Pure Global LATAM MedTech Insight
|
Feb 12, 2026 |
|
Pure Global: Brazil's AI Software Maze - Cracking ANVISA's New Unspoken Code
|
Feb 11, 2026 |
|
Pure Global: Brazil's AI Medical Software Rules - ANVISA's Surprise Roadblock.
|
Feb 10, 2026 |
|
Pure Global: Brazil's AI Software Maze - Cracking ANVISA's New Code
|
Feb 08, 2026 |
|
Pure Global: Mexico's MedTech Shortcut - Unpacking COFEPRIS's New Hurdles
|
Feb 07, 2026 |
|
Pure Global: Brazil's AI MedTech Maze - Cracking ANVISA's New SaMD Rules.
|
Feb 06, 2026 |
|
Pure Global: Brazil's ANVISA Shift & The Hidden Dossier Trap
|
Feb 05, 2026 |
|
Brazil's Digital Health Gauntlet: Pure Global on Cracking ANVISA's New SaMD Code.
|
Feb 03, 2026 |
|
Brazil's SaMD Shake-Up: Pure Global on ANVISA's Hidden AI Rules
|
Feb 02, 2026 |
|
Pure Global: Brazil's New AI Regs—Fast-Track Approval or Data Privacy Nightmare?
|
Feb 01, 2026 |
|
Brazil's RDC 751 Maze: Pure Global on MedTech's Hidden Submission Traps.
|
Jan 31, 2026 |
|
Pure Global: Brazil's RDC 751 Quagmire - A MedTech Survival Guide.
|
Jan 30, 2026 |
|
Brazil's MedTech Shift: Decoding ANVISA's 2027 Roadmap - A Pure Global Insight.
|
Jan 29, 2026 |
|
Brazil's SaMD Shift: Pure Global on Cracking ANVISA's New Digital Health Code
|
Jan 28, 2026 |
|
Pure Global: Mexico's 10-Year MedTech Rule - The New Compliance Marathon
|
Jan 27, 2026 |
|
Brazil's SaMD Shake-Up: A Pure Global Guide to ANVISA's New Digital Health Rules.
|
Jan 26, 2026 |
|
Mexico's 10-Year MedTech Registration: Pure Global on COFEPRIS's Hidden Compliance Trap
|
Jan 25, 2026 |
|
Brazil's SaMD Shift: Pure Global on ANVISA's 2026 Regulatory Gambit
|
Jan 24, 2026 |
|
Pure Global: Mexico City's MedTech Shift - COFEPRIS's 10-Year Bet on Device Renewals.
|
Jan 23, 2026 |
|
Pure Global: Brazil's 3D-Printed MedTech Scramble - Inside ANVISA's Surprise Rule Shake-up.
|
Jan 22, 2026 |
|
Pure Global: Brazil's SaMD Shift - Unpacking ANVISA's Hidden Hurdles for Foreign Tech
|
Jan 21, 2026 |
|
Brazil's AI MedTech Surprise: Decoding ANVISA's New Rules with Pure Global
|
Jan 20, 2026 |
|
Pure Global: Brazil's MedTech Renewal Ambush & ANVISA's Costly Registration Traps
|
Jan 19, 2026 |
|
Pure Global: Brazil's New SaMD Rules - Unseen Compliance Traps for Innovators.
|
Jan 18, 2026 |
|
Pure Global: Brazil's MedTech Shift - Cracking ANVISA's New Digital Labyrinth.
|
Jan 17, 2026 |
|
Pure Global: Brazil's AI MedTech Rush—Fast-Track or Data Privacy Trap?
|
Jan 16, 2026 |
|
Pure Global: Brazil's ANVISA Shockwave - Navigating the New Digital MedTech Registration Chaos.
|
Jan 13, 2026 |
|
Pure Global: Mexico's COFEPRIS Shortcut - A New MedTech Backdoor for US/EU Devices?
|
Jan 12, 2026 |
|
Brazil's AI MedTech Gold Rush: ANVISA's Hidden Rules | Pure Global Insights
|
Jan 11, 2026 |
|
Brazil's AI MedTech Shake-Up: Pure Global on Cracking ANVISA's New Cybersecurity Code
|
Jan 09, 2026 |
|
Pure Global: Brazil's ANVISA 2025 Regs - Navigating Hidden Compliance Traps.
|
Jan 08, 2026 |
|
Pure Global: Decoding Brazil's Shock ANVISA Shift on MedTech Clinical Data.
|
Jan 07, 2026 |
|
Pure Global | Brazil's MedTech Shift: Cracking ANVISA's New Digital Certificate Code
|
Jan 06, 2026 |
|
Pure Global: Mexico's DigiReg Shift - Navigating COFEPRIS's Simplification Paradox
|
Jan 03, 2026 |
|
Pure Global: Mexico's MedTech Shift - Unseen Hurdles in Post-Market Surveillance
|
Jan 02, 2026 |
|
Mexico's Fast-Track Trap: Pure Global on AI MedTech's Hidden Cybersecurity Hurdles.
|
Dec 21, 2025 |
|
Argentina's SaMD Data Tango: Pure Global on ANMAT's Sudden Cybersecurity Shift.
|
Dec 20, 2025 |
|
Pure Global: Brazil's AI Device Gambit—ANVISA's New Rules Create Unexpected Hurdles.
|
Dec 19, 2025 |
|
Brazil's SaMD Gambit: Unlocking ANVISA's New Fast-Track with Pure Global.
|
Dec 18, 2025 |
|
Brazil's SaMD Cybersecurity Shockwave: Pure Global on ANVISA's Hidden Demands.
|
Dec 17, 2025 |
|
Brazil's MDR Surprise: ANVISA's Hidden Clause for MedTech Imports | Pure Global
|
Dec 16, 2025 |
|
Brazil's ANVISA AI Gambit: Pure Global on Hacking the MedTech Approval Backlog.
|
Dec 15, 2025 |
|
Pure Global: Brazil's MedTech Leap to Digital - The Hidden Compliance Traps.
|
Dec 14, 2025 |
|
São Paulo SaMD Shake-Up: Pure Global on ANVISA’s Unwritten Rules for AI
|
Dec 13, 2025 |
|
Pure Global LATAM Insights: Brazil's SaMD Shakeup - Decoding ANVISA's 2025 Digital Health Playbook.
|
Dec 12, 2025 |
|
Pure Global: Brazil's MedTech Data Shock - ANVISA's New Cybersecurity Surprise
|
Dec 11, 2025 |
|
Brazil's AI MedTech Leap: Pure Global on Cracking ANVISA's New SaMD Code
|
Dec 10, 2025 |
|
Pure Global: Brazil's Clinical Trial Overhaul - The MedTech Insider's Playbook
|
Dec 09, 2025 |
|
Navigating Brazil's ANVISA RDC 751 & RDC 830: A Pure Global Guide to LATAM MedTech & IVD Market Access Success
|
Oct 17, 2025 |
|
Unlocking LATAM MedTech: How Pure Global Leverages Market Intelligence on Colombia and Brazil for Strategic Entry
|
Oct 16, 2025 |
|
Pure Global's Deep Dive into Brazil: Mastering ANVISA MedTech Regulations with an Integrated Registration & PMS Strategy
|
Oct 15, 2025 |
|
Fast-Track Your LATAM Entry: Pure Global’s Guide to Colombia’s Automatic Registration for Low-Risk MedTech and Navigating High-Risk Approvals.
|
Oct 14, 2025 |
|
Cracking Argentina's ANMAT: A MedTech Manufacturer's Guide to Local Registration Success with Pure Global
|
Oct 13, 2025 |
|
Pure Global's Guide to Peru: Navigating DIGEMID and the Essential Role of a Local Registration Holder for MedTech Success
|
Oct 12, 2025 |
|
Pure Global's LATAM MedTech Insights: Unlocking a Decade of Market Access with Colombia's 10-Year INVIMA Registration.
|
Oct 11, 2025 |
|
Navigating Brazil's 2025 UDI Mandate: A Pure Global Guide to ANVISA's SIUD for MedTech Success in LATAM
|
Oct 10, 2025 |
|
Unlocking Brazil's MedTech Market: A Pure Global Deep Dive into ANVISA's Class I/II Notification and High-Risk Registration Pathways
|
Oct 09, 2025 |
|
LATAM MedTech Insights by Pure Global: Unlocking the Mexican Market with COFEPRIS's New Abbreviated Pathway and Homologation Reforms
|
Oct 08, 2025 |
|
Pure Global's Guide to Mexico's MedTech Market: The Critical Role of the COFEPRIS Registration Holder (MRH)
|
Oct 07, 2025 |
|
Navigating LATAM MedTech Regulations for Surgical Instruments & ESUs: A Pure Global Guide to Brazil's ANVISA & Mexico's COFEPRIS
|
Oct 06, 2025 |
|
LATAM MedTech Insights by Pure Global: Unlocking the Anesthesia Equipment Market in Brazil, Mexico, and Beyond - A Regulatory Deep Dive
|
Oct 05, 2025 |
|
The LATAM Diabetes Tech Boom: Pure Global's Guide to Regulatory Success for Blood Glucose Monitors in Brazil, Mexico, and Argentina.
|
Oct 04, 2025 |
|
The Goldmine and the Maze: Pure Global's Guide to Launching Orthopedic Surgical Implants in Brazil, Mexico, and Beyond.
|
Oct 03, 2025 |
|
Navigating LATAM's Heartbeat: A Pure Global Deep Dive into Brazil's ANVISA & Mexico's COFEPRIS for Cardiac Monitoring & ECG Device Approval
|
Oct 02, 2025 |
|
Pure Global LATAM MedTech Insights: Cracking the Code of the Digital X-ray Market in Brazil, Mexico, and Colombia - Your Guide to ANVISA & COFEPRIS Regulatory Hurdles.
|
Oct 01, 2025 |
|
Unlocking LATAM's Vision: Pure Global's Expert Guide to Endoscopic Imaging Market Access in Brazil, Mexico, and Colombia
|
Sep 30, 2025 |
|
Unlocking LATAM's MedTech Potential: Pure Global's Guide to Navigating the Infusion Pump Market in Brazil, Mexico, and Colombia
|
Sep 29, 2025 |
|
LATAM's New Breath: Navigating Brazil's Ventilator Surplus and Mexico's Regulatory Maze in Respiratory MedTech with Pure Global.
|
Sep 28, 2025 |
|
Navigating Brazil & Mexico's Hemodialysis Market: A Pure Global Guide to ANVISA and COFEPRIS for MedTech Innovators in LATAM
|
Sep 27, 2025 |
|
Cracking the Code of LATAM MedTech with Pure Global: A Deep Dive into Peru's Supreme Decree 016-2011-SA and its Impact on Medical Device Registration
|
Sep 26, 2025 |
|
Navigating Chile's Technovigilance Maze: A Pure Global Breakdown of Resolution 1618/2020 for MedTech Market Access in LATAM
|
Sep 25, 2025 |
|
Pure Global's MedTech Guide: Mastering Brazil's ANVISA RDC 497/2021 for Your Device Registration and GMP Certification Update
|
Sep 24, 2025 |
|
Information Not Found
|
Sep 23, 2025 |
|
Unlocking the Colombian MedTech Market: A Pure Global Expert Guide to Medical Device Registration under Decree 4725 of 2005
|
Sep 22, 2025 |
|
LATAM MedTech Insights by Pure Global: Mastering Argentina's ANMAT Renewal Under Disposition 2318/2002 to Secure Your Market Access.
|
Sep 21, 2025 |
|
Pure Global Presents LATAM MedTech Insights: Mastering Mexico's NOM-241 GMP for Medical Device Manufacturing Success
|
Sep 20, 2025 |
|
Cracking the Code of Mexican MedTech: Pure Global's Guide to NOM-137-SSA1-2008 Labeling for LATAM Success
|
Sep 19, 2025 |
|
LATAM MedTech Insights: A Pure Global Guide to Brazil's INMETRO Ordinance 384/2020 for Medical Device Compliance and Market Access
|
Sep 18, 2025 |
|
Pure Global's Deep Dive into ANVISA RDC 751/2022: Unlocking Brazil's MedTech Potential for Global Innovators
|
Sep 17, 2025 |
|
LATAM MedTech Insights: Pure Global's Guide to Brazil's 30-Day ANVISA Approval for Class II SaMD
|
Sep 16, 2025 |
|
Navigating Colombia's MedTech Market with Pure Global: Why Your Choice of Local Representative for INVIMA Registration is Mission-Critical for LATAM Success
|
Sep 15, 2025 |
|
Cracking COFEPRIS: Pure Global's Essential Guide to Mexico's Software Medical Device Labeling and Spanish Language Requirements
|
Sep 14, 2025 |
|
Unlocking Brazil's SaMD Market: Why ISO 13485 Isn't Enough and How MDSAP is Your Key to Faster ANVISA Approval with Pure Global
|
Sep 13, 2025 |
|
Pure Global's Insider Guide: Fast-Tracking Foreign AI Medical Device Registration with Mexico's COFEPRIS, a Deep Dive for MedTech Innovators.
|
Sep 12, 2025 |
|
Unlocking Brazil: Pure Global's Guide to ANVISA's Clinical Data Requirements for SaMD in LATAM
|
Sep 11, 2025 |
|
Navigating ANMAT's Stance on AI Medical Devices in Argentina: A Pure Global LATAM MedTech Insights Deep Dive
|
Sep 10, 2025 |
|
Unlocking Colombia's MedTech Market: A Pure Global Deep Dive into INVIMA's Software as a Medical Device (SaMD) Registration Requirements
|
Sep 09, 2025 |
|
Pure Global's LATAM MedTech Insights: Decoding COFEPRIS's New Rules for AI-Powered Medical Software Classification in Mexico
|
Sep 08, 2025 |
|
Pure Global Presents: Decoding ANVISA's AI & SaMD Regulations for MedTech Success in Brazil & LATAM
|
Sep 07, 2025 |
|
Navigating ANVISA in Brazil: Pure Global Explains the Surprising GMP Rule for Class I Medical Devices in LATAM
|
Sep 06, 2025 |
|
Pure Global Presents: The LATAM Labeling Labyrinth - Mastering Low-Risk Medical Device Requirements with Brazil's ANVISA, Mexico's COFEPRIS & More
|
Sep 05, 2025 |
|
Unlocking Brazil's MedTech Market: The Critical Role of a Brazil Registration Holder for Class I Devices | A Pure Global Insight for LATAM Expansion
|
Sep 04, 2025 |
|
Unlocking MedTech in Colombia: A Pure Global Guide to INVIMA's Fast-Track Notification for Low-Risk Devices in LATAM
|
Sep 03, 2025 |
|
Cracking the ANMAT Code with Pure Global: The Surprising Truth About Class I Medical Device Registration in Argentina
|
Sep 02, 2025 |
|
Cracking the COFEPRIS Code for LATAM Expansion: Pure Global's Expert Guide on Low-Risk Medical Device Registration in Mexico.
|
Sep 01, 2025 |
|
Brazil's MedTech Maze: A Pure Global Guide to ANVISA's "Cadastro" and "Notificação" for Class I Devices
|
Aug 31, 2025 |
|
The Mercosur MedTech Myth: Is a Single Device Registration for Brazil, Argentina, and LATAM a Reality? A Pure Global Deep Dive.
|
Aug 30, 2025 |
|
Colombia's INVIMA Timelines: A Pure Global Deep Dive on Medical Device Registration Delays and How to Navigate the LATAM Market
|
Aug 29, 2025 |
|
Cracking the Code of Brazil's BGMP: A LATAM MedTech Insight from Pure Global on Navigating ANVISA Inspections for Market Success.
|
Aug 28, 2025 |
|
Unlocking the Peruvian MedTech Market: A Pure Global Breakdown of Medical Device Registration Costs and Hidden Fees in LATAM
|
Aug 27, 2025 |
|
LATAM MedTech Insights by Pure Global: Leveraging FDA Approval & CE Marks for Medical Device Registration in Chile's Evolving Market
|
Aug 26, 2025 |
|
Navigating INVIMA: A Guide to Colombia's Spanish Medical Device Labeling Requirements with Pure Global's Expert Insights
|
Aug 25, 2025 |
|
Pure Global's Guide to ANMAT: Why Your Choice of Medical Device Registration Holder in Argentina Can Make or Break Your LATAM Market Access.
|
Aug 24, 2025 |
|
Navigating MedTech in LATAM: A Pure Global Deep Dive into Medical Device Classification Rules in Brazil, Mexico, and Colombia
|
Aug 23, 2025 |
|
From FDA to LATAM: How Pure Global Helps Navigate the COFEPRIS Medical Device Pathway in Mexico for Faster Market Access
|
Aug 22, 2025 |
|
LATAM MedTech Insights by Pure Global: A Strategic Guide to ANVISA Medical Device Registration in Brazil
|
Aug 21, 2025 |
|
Unlocking Brazil's MedTech Market: A Pure Global Deep Dive on ANVISA Medical Device Registration for Your LATAM Strategy
|
Aug 19, 2025 |